UV-visible spectroscopy as an alternative to liquid chromatography for determination of everolimus in surfactant-containing dissolution media: a useful approach based on solid-phase extraction.
High-throughput 96-well solid phase extraction (SPE) plate with C-18 reversed phase sorbent followed by UV-visible (UV-Vis) microplate reader was applied to the analysis of hydrophobic drugs in surfactant-containing dissolution media, which are often used to evaluate the in-vitro drug release of drug eluting stents (DES). Everolimus and dissolution medium containing Triton X-405 were selected as representatives, and the appropriate SPE conditions (adsorption, washing and elution) were investigated to obtain a practical and reliable sample clean-up. It was shown that the developed SPE procedure was capable of removing interfering components (Triton X-405 and its impurities), allowing for an accurate automated spectrophotometric analysis to be performed. The proposed UV-Vis spectrophotometric method yielded equivalent results compared to a classical LC analysis method. Linear regression analysis indicated that both methods have the ability to obtain test results that are directly proportional to the concentration of analyte in the sample within the selected range of 1.0-10 μg/ml for everolimus, with a coefficient of correlation (r(2)) value of >0.998 and standard deviation of the residuals (Syx) of <2%. The individual recoveries of everolimus ranged from 97 to 104% for the UV-Vis spectrophotometric method and from 98 to 102 for the HPLC method, respectively. The 95% CI of the mean recovery for the UV-Vis spectrophotometric method was 99-102% and for the HPLC method was 99-101%. No statistical difference was found between the mean recoveries of the methods (p=0.42). Hence the methods are free from interference due to Triton and other chemicals present in the dissolution medium. The variation in the amount of everolimus estimated by UV-Vis spectrophotometric and HPLC methods was ≤3.5%, and the drug release profiles obtained by both methods were found to be equivalent by evaluation with two-one-sided t-test (two-tailed, p=0.62; mean of differences, 0.17; 95% CI, 0.62-0.96) and similarity factor f2 (f2 value, 87). The excellent conformity of the results makes UV-Vis spectrophotometer an ideal tool for analyzing the drugs in the media containing surfactants, after SPE. The 96-well SPE plates in combination with UV-Vis microplate reader provide a high throughput method for the determination of in-vitro drug release profile of DES. Switching from HPLC to UV-Vis spectrophotometer microplate reader assay reduces the solvent consumption and labor required for the sample analyses. This directly impacts the profitability of the laboratory.
Department of Analytical Sciences, Abbott Vascular, Inc., Santa Clara, CA 95054-2807, USA. kmarika55@hotmail.com
Marika
M
Kamberi
Thu-Ngoc
TN
Tran
D002138:Calibration; D002317:Cardiovascular Agents / Q000032:analysis* / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid; D004355:Drug Stability; D004867:Equipment Design; D000068338:Everolimus; D057166:High-Throughput Screening Assays; D057927:Hydrophobic and Hydrophilic Interactions; D007700:Kinetics; D057230:Limit of Detection; D016014:Linear Models; D011092:Polyethylene Glycols / Q000737:chemistry*; D012015:Reference Standards; D015203:Reproducibility of Results; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000032:analysis / Q000737:chemistry; D052616:Solid Phase Extraction / Q000295:instrumentation / Q000592:standards; D012995:Solubility; D013056:Spectrophotometry, Ultraviolet / Q000295:instrumentation / Q000592:standards; D013501:Surface-Active Agents / Q000737:chemistry*
D002317:Cardiovascular Agents; D013501:Surface-Active Agents; D011092:Polyethylene Glycols; D000068338:Everolimus; D020123:Sirolimus